title: Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop.
authors.affiliation: Washington, DC, United States.
authors.forename: Prashant
authors.initials: P
authors.lastname: Nair
authors.affiliation: Joslin Diabetes Center, Boston, Massachusetts, United States.
authors.forename: Lloyd Paul
authors.initials: LP
authors.lastname: Aiello
authors.affiliation: University of Michigan, Ann Arbor, Michigan, United States.
authors.forename: Thomas W
authors.initials: TW
authors.lastname: Gardner
authors.affiliation: Northwestern University, Chicago, Illinois, United States.
authors.forename: Lee M
authors.initials: LM
authors.lastname: Jampol
authors.affiliation: National Eye Institute, Bethesda, Maryland, United States.
authors.forename: Frederick L
authors.initials: FL
authors.lastname: Ferris
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods*; D003226:Congresses as Topic; D003930:Diabetic Retinopathy / Q000628:therapy*; D006801:Humans; D054554:National Eye Institute (U.S.); D014481:United States; D014486:United States Food and Drug Administration